Status
Conditions
Treatments
About
To assess the safety and effectiveness of the Juvene® IOL for the treatment of aphakia and mitigation of the effects of presbyopia after removal of the natural crystalline lens due to cataract.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
56 participants in 2 patient groups
Loading...
Central trial contact
Patrick R Casey, O.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal